Characterization of amphotericin B aerosols for inhalation treatment of pulmonary aspergillosis
- 1 September 1996
- journal article
- Published by Springer Nature in Infection
- Vol. 24 (5), 354-360
- https://doi.org/10.1007/bf01716078
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Use of amphotericin B aerosols for the prevention of pulmonary aspergillosisInfection, 1994
- Estimation of the times for evaporation of pure water droplets and for stabilization of salt solution particlesJournal of Aerosol Science, 1990
- Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published CasesClinical Infectious Diseases, 1990
- Intercomparison of Experimental Regional Aerosol Deposition DataJournal of Aerosol Medicine, 1989
- Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosisAntimicrobial Agents and Chemotherapy, 1988
- MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus sppAntimicrobial Agents and Chemotherapy, 1988
- Deposition of particles in the human respiratory tract in the size range 0.005–15 μmJournal of Aerosol Science, 1986
- Distribution and Activity of Amphotericin B in HumansThe Journal of Infectious Diseases, 1985
- Experimental determination of the regional deposition of aerosol particles in the human respiratory tractAihaj Journal, 1980
- Generation and properties of a condensation aerosol of di-2-ethylhexyl sebacate (DES)—I: Description of the generatorJournal of Aerosol Science, 1975